These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37395475)

  • 41. Outcomes of patients treated with a biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stents after rotational atherectomy.
    Mankerious N; Hemetsberger R; Traboulsi H; Toelg R; Abdel-Wahab M; Richardt G; Allali A
    Clin Res Cardiol; 2021 Oct; 110(10):1574-1585. PubMed ID: 33861369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
    Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T
    Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.
    Jaguszewski M; Dörig M; Frangieh AH; Ghadri JR; Cammann VL; Diekmann J; Napp LC; D'Ascenzo F; Imori Y; Obeid S; Maier W; Lüscher TF; Templin C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):E173-E182. PubMed ID: 27377554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease.
    Kufner S; Joner M; Thannheimer A; Hoppmann P; Ibrahim T; Mayer K; Cassese S; Laugwitz KL; Schunkert H; Kastrati A; Byrne RA;
    Circulation; 2019 Jan; 139(3):325-333. PubMed ID: 30586724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes mellitus: 5 years follow-up from the COMPARE II trial.
    Paradies V; Vlachojannis GJ; Royaards KJ; Wassing J; van der Ent M; Smits PC
    Int J Cardiol; 2019 Sep; 290():40-44. PubMed ID: 31101545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of MECHANISM of early and late vascular responses following treatment of ST-elevation acute myocardial infarction with two different everolimus-eluting stents: a randomized controlled trial of biodegradable versus durable polymer stents.
    Otake H; Ishida M; Nakano S; Higuchi Y; Hibi K; Kuriyama N; Iwasaki M; Kataoka T; Kubo T; Tsujita K; Ashikaga T; Shinke T; Itoh T; Kimura T; Morino Y;
    Cardiovasc Interv Ther; 2023 Jan; 38(1):75-85. PubMed ID: 35896895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two-year real world clinical outcomes after intravascular imaging device guided percutaneous coronary intervention with ultrathin-strut biodegradable-polymer sirolimus-eluting stent.
    Nakao S; Ishihara T; Tsujimura T; Hata Y; Higashino N; Kusuda M; Mano T
    Int J Cardiol; 2024 Mar; 399():131686. PubMed ID: 38151161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term comparison of everolimus-eluting and biolimus-eluting stents.
    Puricel S; Oberhänsli M; Guntern P; Lehmann S; Goy JJ; Arroyo D; Villeneuve H; Baeriswyl G; Stauffer JC; Togni M; Cook S
    EuroIntervention; 2013 Jul; 9(3):336-44. PubMed ID: 23482296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison between biodegradable- and durable-polymer everolimus-eluting stents in hemodialysis patients with coronary artery disease.
    Ito R; Ishii H; Oshima S; Nakayama T; Sakakibara T; Kakuno M; Murohara T
    Cardiovasc Interv Ther; 2022 Jul; 37(3):475-482. PubMed ID: 34817827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two-year vascular responses to drug-eluting stents with biodegradable polymer versus durable polymer: An optical coherence tomography sub-study of the NEXT.
    Katayama Y; Kubo T; Akasaka T; Ino Y; Kimura K; Okura H; Shinke T; Igarashi K; Kadota K; Kozuma K; Tanabe K; Nakagawa Y; Muramatsu T; Morino Y; Kimura T;
    J Cardiol; 2017 Dec; 70(6):530-536. PubMed ID: 28536015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of biodegradable polymer biolimus A9-eluting stent versus durable polymer everolimus-eluting stent in diabetic patients: a prospective non-randomized single-centre long-term comparison.
    Sprimont P; Pierard S; Vanoverschelde JL; Debbas N
    Acta Cardiol; 2014 Oct; 69(5):523-31. PubMed ID: 25638840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomised comparison of coronary stents according to short or prolonged durations of dual antiplatelet therapy in patients with acute coronary syndromes: a pre-specified analysis of the SMART-DATE trial.
    Jang WJ; Lee JB; Song YB; Choi KH; Choi SH; Chun WJ; Oh JH; Park IH; Doh JH; Jeong JO; Park JS; Gwon HC; Hahn JY
    EuroIntervention; 2021 Aug; 17(5):e411-e417. PubMed ID: 33136005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
    Puricel S; Arroyo D; Corpataux N; Baeriswyl G; Lehmann S; Kallinikou Z; Muller O; Allard L; Stauffer JC; Togni M; Goy JJ; Cook S
    J Am Coll Cardiol; 2015 Mar; 65(8):791-801. PubMed ID: 25720622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angioscopic Comparison of Early- and Mid-Term Vascular Responses Following Treatment of ST-Elevation Acute Myocardial Infarction With Biodegradable vs. Durable Polymer Everolimus-Eluting Stents　- A Prespecified Subanalysis of the MECHANISM AMI RCT.
    Nakatani S; Sotomi Y; Suzuki S; Kobayashi T; Hamanaka Y; Omatsu T; Ishida M; Kakizaki S; Otake H; Morino Y; Higuchi Y;
    Circ J; 2023 Apr; 87(5):619-628. PubMed ID: 36418112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-Term Percutaneous Coronary Intervention Outcomes in Chronic Versus Acute Coronary Syndromes (TARGET All Comers Trial).
    Patel KP; Lansky AJ; Kelbæk H; Xu B; van Royen N; Johnson TW; Anderson R; Wijns W; Baumbach A;
    Am J Cardiol; 2024 Apr; 217():94-101. PubMed ID: 38350507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.
    Iglesias JF; Muller O; Losdat S; Roffi M; Kurz DJ; Weilenmann D; Kaiser C; Heg D; Valgimigli M; Windecker S; Pilgrim T
    Int J Cardiol; 2021 Jul; 334():37-41. PubMed ID: 33887341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial.
    Wöhrle J; Markovic S; Rottbauer W; Muramatsu T; Kadota K; Vázquez-González N; Odenstedt J; Serra A; Antoniucci D; Varenne O; Saito S; Wijns W
    EuroIntervention; 2016 Jun; 12(2):e167-74. PubMed ID: 27290676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2019 May; 284():102-109. PubMed ID: 30877937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial.
    Iglesias JF; Heg D; Roffi M; Degrauwe S; Tüller D; Muller O; Brinkert M; Cook S; Weilenmann D; Kaiser C; Cuculi F; Valgimigli M; Jüni P; Windecker S; Pilgrim T
    Cardiovasc Revasc Med; 2022 Jan; 34():3-10. PubMed ID: 33653633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial.
    Iglesias JF; Muller O; Losdat S; Roffi M; Kurz DJ; Weilenmann D; Kaiser C; Heg D; Windecker S; Pilgrim T
    Catheter Cardiovasc Interv; 2023 Mar; 101(4):687-700. PubMed ID: 36807456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.